As a leading Animal Health company, Bayer Animal Health is a strong believer in the power of partnerships and we are always looking to partner with public and private institutions interested on working with us to identify new and innovative animal health solutions aligned with our values and strategic focus.

Our vision is simple yet very solid. We want to be the customer’s first choice for animal health and well-being, and we know that partnerships give us the opportunity to combine the innovation generated by potential likeminded partners with our comprehensive scientific, manufacturing and commercial expertise and capabilities, all for the benefit of animals. Because we truly believe that healthy animals make the world a better place.

Why partner with us?

Based on almost 100 years of continuous innovation, we work with over 90 organizations across the world to help care for and protect animals. From rhinos in Africa to dogs in Cambodia, we are delivering support when and where it is needed in local communities. We partner with leading research institutes, universities think-tanks and laboratories to prepare for future animal health challenges, including parasitic, infectious, chronic, and zoonotic diseases.

Bayer Animal Health has a long-term record of successful partnerships involving both large and small companies or academic institutions.

What are we interested in?

While aiming for flexible and innovative deal structures, our partnering philosophy is focused on building long term partnering relations across the globe in the following areas: Farm Animals and Companion Animals.

Our partnering strategy goes from early development (@Proof-of-Concept stage) to commercialized products.

 

Our key areas

Early & Late-stage assets and new technologies for:

  • Parasite control: prevention and treatment
  • Inflammation
  • Immunomodulation
  • Animal management optimization
  • Fertility enhancement
  • Mammary gland health and optimization of milk production
  • Antibiotic alternatives
  • Microbiome modulation
  • Calf health
  • Metabolic health
  • Lifespan/wellbeing improvement

Early & Late-stage assets and new technologies for:

  • Parasite control: prevention and treatment
  • Inflammation and allergy
  • Pain
  • Immunomodulation
  • Cardiovascular/renal diseases
  • Microbiome modulation
  • Chronic conditions and quality of life in aging pets

Latest partnerships

How to get in touch with us?

Maximize the value of your innovation by partnering with Bayer. Just use our contact form and our Business Development & Licensing team will contact you in order to promptly confirm the path forward.